The change in differentiation state driven by MSI2-HOXA9 cells suggested that when coupled with BCR-ABL, MSI2-HOXA9 can drive chronic phase CML to blast crisis, and thus serve as an oncogene. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.